# Parker-Hannifin Corp: financial statements, quarterly

PH · NYSE · CIK 76334 · [Industrials](/sectors/industrials.md) · fiscal year ends Jun 30

Pages: [Overview](/companies/ph.md) · [Financials](/companies/ph/financials.md) · [Filings](/companies/ph/filings.md) · [Insiders](/companies/ph/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ph/financials.md?period=annual).

## Income statement

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [4,847](/filings/0000076334-24-000067.md) | [4,821](/filings/0000076334-25-000011.md) | [5,074](/filings/0000076334-25-000021.md) | [5,187 d](/filings/0000076334-26-000105.md) | [4,904](/filings/0000076334-25-000071.md) | [4,743](/filings/0000076334-26-000008.md) | [4,960](/filings/0000076334-26-000073.md) | [5,243 d](/filings/0000076334-26-000105.md) | [5,084](/filings/0000076334-25-000071.md) | [5,174](/filings/0000076334-26-000008.md) | [5,486](/filings/0000076334-26-000073.md) | [5,755 d](/filings/0000076334-26-000105.md) |
| Cost of revenue | $m | [3,097](/filings/0000076334-24-000067.md) | [3,102](/filings/0000076334-25-000011.md) | [3,280](/filings/0000076334-25-000021.md) | [3,323 d](/filings/0000076334-26-000105.md) | [3,098](/filings/0000076334-25-000071.md) | [3,022](/filings/0000076334-26-000008.md) | [3,130](/filings/0000076334-26-000073.md) | [3,285 d](/filings/0000076334-26-000105.md) | [3,177](/filings/0000076334-25-000071.md) | [3,243](/filings/0000076334-26-000008.md) | [3,469](/filings/0000076334-26-000073.md) | [3,508 d](/filings/0000076334-26-000105.md) |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [874](/filings/0000076334-24-000067.md) | [807](/filings/0000076334-25-000011.md) | [816](/filings/0000076334-25-000021.md) | [818 d](/filings/0000076334-26-000105.md) | [849](/filings/0000076334-25-000071.md) | [782](/filings/0000076334-26-000008.md) | [785](/filings/0000076334-26-000073.md) | [839 d](/filings/0000076334-26-000105.md) | [873](/filings/0000076334-25-000071.md) | [837](/filings/0000076334-26-000008.md) | [884](/filings/0000076334-26-000073.md) | [874 d](/filings/0000076334-26-000105.md) |
| Operating income | $m | [977](/filings/0000076334-24-000067.md) | [966](/filings/0000076334-25-000011.md) | [1,033](/filings/0000076334-25-000021.md) | [1,093 d](/filings/0000076334-26-000105.md) | [1,058](/filings/0000076334-25-000071.md) | [992](/filings/0000076334-26-000008.md) | [1,108](/filings/0000076334-26-000073.md) | [1,189 d](/filings/0000076334-26-000105.md) | [1,183](/filings/0000076334-25-000071.md) | [1,182](/filings/0000076334-26-000008.md) | [1,229](/filings/0000076334-26-000073.md) | [1,474 d](/filings/0000076334-26-000105.md) |
| Interest expense | $m | [134](/filings/0000076334-23-000064.md) | [129](/filings/0000076334-24-000008.md) | [124](/filings/0000076334-24-000020.md) | [119 d](/filings/0000076334-26-000105.md) | [113](/filings/0000076334-25-000071.md) | [101](/filings/0000076334-26-000008.md) | [96.0](/filings/0000076334-26-000073.md) | [99.0 d](/filings/0000076334-26-000105.md) | [101](/filings/0000076334-25-000071.md) | [106](/filings/0000076334-26-000008.md) | [99.0](/filings/0000076334-26-000073.md) | [95.0 d](/filings/0000076334-26-000105.md) |
| Income tax | $m | [169](/filings/0000076334-24-000067.md) | [186](/filings/0000076334-25-000011.md) | [193](/filings/0000076334-25-000021.md) | [201 d](/filings/0000076334-26-000105.md) | [177](/filings/0000076334-25-000071.md) | [217](/filings/0000076334-26-000008.md) | [33.0](/filings/0000076334-26-000073.md) | [148 d](/filings/0000076334-26-000105.md) | [232](/filings/0000076334-25-000071.md) | [219](/filings/0000076334-26-000008.md) | [215](/filings/0000076334-26-000073.md) | [248 d](/filings/0000076334-26-000105.md) |
| Net income | $m | [651](/filings/0000076334-24-000067.md) | [682](/filings/0000076334-25-000011.md) | [727](/filings/0000076334-25-000021.md) | [784 d](/filings/0000076334-24-000044.md) | [698](/filings/0000076334-25-000071.md) | [949](/filings/0000076334-26-000008.md) | [962](/filings/0000076334-26-000073.md) | [923 d](/filings/0000076334-26-000105.md) | [808](/filings/0000076334-25-000071.md) | [845](/filings/0000076334-26-000008.md) | [904](/filings/0000076334-26-000073.md) | [1,092 d](/filings/0000076334-26-000105.md) |
| Diluted EPS | $ per share | [4.99](/filings/0000076334-24-000067.md) | [5.23](/filings/0000076334-25-000011.md) | [5.56](/filings/0000076334-25-000021.md) | not reported | [5.34](/filings/0000076334-25-000071.md) | [7.25](/filings/0000076334-26-000008.md) | [7.37](/filings/0000076334-26-000073.md) | not reported | [6.29](/filings/0000076334-25-000071.md) | [6.60](/filings/0000076334-26-000008.md) | [7.06](/filings/0000076334-26-000073.md) | not reported |
| Basic EPS | $ per share | [5.07](/filings/0000076334-24-000067.md) | [5.31](/filings/0000076334-25-000011.md) | [5.65](/filings/0000076334-25-000021.md) | not reported | [5.43](/filings/0000076334-25-000071.md) | [7.37](/filings/0000076334-26-000008.md) | [7.48](/filings/0000076334-26-000073.md) | not reported | [6.39](/filings/0000076334-25-000071.md) | [6.69](/filings/0000076334-26-000008.md) | [7.16](/filings/0000076334-26-000073.md) | not reported |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: not reported
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:ProfitLoss, us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.4](/filings/0000076334-23-000064.md) | [0.4](/filings/0000076334-24-000008.md) | [0.4](/filings/0000076334-24-000020.md) | [0.4](/filings/0000076334-25-000035.md) | [0.4](/filings/0000076334-24-000067.md) | [0.4](/filings/0000076334-25-000011.md) | [0.4](/filings/0000076334-25-000021.md) | [0.5](/filings/0000076334-26-000105.md) | [0.5](/filings/0000076334-25-000071.md) | [0.4](/filings/0000076334-26-000008.md) | [0.5](/filings/0000076334-26-000073.md) | [0.5](/filings/0000076334-26-000105.md) |
| Current assets | $bn | [6.8](/filings/0000076334-23-000064.md) | [6.7](/filings/0000076334-24-000008.md) | [6.9](/filings/0000076334-24-000020.md) | [6.8](/filings/0000076334-25-000035.md) | [7.0](/filings/0000076334-24-000067.md) | [6.3](/filings/0000076334-25-000011.md) | [6.8](/filings/0000076334-25-000021.md) | [7.0](/filings/0000076334-26-000105.md) | [7.2](/filings/0000076334-25-000071.md) | [7.2](/filings/0000076334-26-000008.md) | [7.6](/filings/0000076334-26-000073.md) | [7.7](/filings/0000076334-26-000105.md) |
| Total assets | $bn | [29.6](/filings/0000076334-23-000064.md) | [29.7](/filings/0000076334-24-000008.md) | [29.6](/filings/0000076334-24-000020.md) | [29.3](/filings/0000076334-26-000105.md) | [29.6](/filings/0000076334-24-000067.md) | [28.3](/filings/0000076334-25-000011.md) | [28.9](/filings/0000076334-25-000021.md) | [29.5](/filings/0000076334-26-000105.md) | [30.7](/filings/0000076334-25-000071.md) | [30.5](/filings/0000076334-26-000008.md) | [30.7](/filings/0000076334-26-000073.md) | [30.9](/filings/0000076334-26-000105.md) |
| Current liabilities | $bn | [7.7](/filings/0000076334-23-000064.md) | [7.5](/filings/0000076334-24-000008.md) | [8.0](/filings/0000076334-24-000020.md) | [7.3](/filings/0000076334-25-000035.md) | [7.3](/filings/0000076334-24-000067.md) | [6.0](/filings/0000076334-25-000011.md) | [5.6](/filings/0000076334-25-000021.md) | [5.8](/filings/0000076334-26-000105.md) | [6.8](/filings/0000076334-25-000071.md) | [6.1](/filings/0000076334-26-000008.md) | [6.7](/filings/0000076334-26-000073.md) | [6.1](/filings/0000076334-26-000105.md) |
| Total liabilities | $bn | [19.0](/filings/0000076334-23-000064.md) | [18.4](/filings/0000076334-24-000008.md) | [18.0](/filings/0000076334-24-000020.md) | [17.2](/filings/0000076334-25-000035.md) | [16.7](/filings/0000076334-24-000067.md) | [15.1](/filings/0000076334-25-000011.md) | [15.5](/filings/0000076334-25-000021.md) | [15.8](/filings/0000076334-26-000105.md) | [16.9](/filings/0000076334-25-000071.md) | [16.2](/filings/0000076334-26-000008.md) | [16.1](/filings/0000076334-26-000073.md) | [15.5](/filings/0000076334-26-000105.md) |
| Long-term debt | $bn | not reported | not reported | not reported | [8.4](/filings/0000076334-25-000035.md) | not reported | not reported | not reported | [7.5](/filings/0000076334-26-000105.md) | not reported | not reported | not reported | [7.5](/filings/0000076334-26-000105.md) |
| Current portion of debt | $bn | [3.6](/filings/0000076334-23-000064.md) | [3.7](/filings/0000076334-24-000008.md) | [4.1](/filings/0000076334-24-000020.md) | [1.3](/filings/0000076334-25-000035.md) | not reported | not reported | not reported | [0.0](/filings/0000076334-26-000105.md) | not reported | not reported | not reported | [0.7](/filings/0000076334-26-000105.md) |
| Short-term borrowings | $bn | [1.6](/filings/0000076334-23-000064.md) | [1.2](/filings/0000076334-24-000008.md) | [0.8](/filings/0000076334-24-000020.md) | [2.1](/filings/0000076334-25-000035.md) | [1.8](/filings/0000076334-24-000067.md) | [1.6](/filings/0000076334-25-000011.md) | [1.9](/filings/0000076334-25-000021.md) | [1.8](/filings/0000076334-26-000105.md) | [2.8](/filings/0000076334-25-000071.md) | [2.4](/filings/0000076334-26-000008.md) | [2.1](/filings/0000076334-26-000073.md) | [1.0](/filings/0000076334-26-000105.md) |
| Shareholders' equity | $bn | [10.6](/filings/0000076334-23-000064.md) | [11.3](/filings/0000076334-24-000008.md) | [11.6](/filings/0000076334-24-000020.md) | [12.1](/filings/0000076334-25-000035.md) | [12.9](/filings/0000076334-24-000067.md) | [13.1](/filings/0000076334-25-000011.md) | [13.4](/filings/0000076334-25-000021.md) | [13.7](/filings/0000076334-26-000105.md) | [13.8](/filings/0000076334-25-000071.md) | [14.3](/filings/0000076334-26-000008.md) | [14.6](/filings/0000076334-26-000073.md) | [15.4](/filings/0000076334-26-000105.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: us-gaap:LongTermDebtCurrent, us-gaap:DebtCurrent
- Short-term borrowings: us-gaap:CommercialPaper
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [650](/filings/0000076334-24-000067.md) | [702 d](/filings/0000076334-25-000011.md) | [795 d](/filings/0000076334-25-000021.md) | [1,237 d](/filings/0000076334-26-000105.md) | [744](/filings/0000076334-25-000071.md) | [935 d](/filings/0000076334-26-000008.md) | [630 d](/filings/0000076334-26-000073.md) | [1,467 d](/filings/0000076334-26-000105.md) | [782](/filings/0000076334-25-000071.md) | [862 d](/filings/0000076334-26-000008.md) | [984 d](/filings/0000076334-26-000073.md) | [1,736 d](/filings/0000076334-26-000105.md) |
| Capital expenditure | $m | [97.7](/filings/0000076334-24-000067.md) | [106 d](/filings/0000076334-25-000011.md) | [79.2 d](/filings/0000076334-25-000021.md) | [117 d](/filings/0000076334-26-000105.md) | [95.0](/filings/0000076334-25-000071.md) | [121 d](/filings/0000076334-26-000008.md) | [88.0 d](/filings/0000076334-26-000073.md) | [131 d](/filings/0000076334-26-000105.md) | [89.0](/filings/0000076334-25-000071.md) | [94.0 d](/filings/0000076334-26-000008.md) | [103 d](/filings/0000076334-26-000073.md) | [173 d](/filings/0000076334-26-000105.md) |
| Dividends paid | $m | [190](/filings/0000076334-24-000067.md) | [191 d](/filings/0000076334-25-000011.md) | [190 d](/filings/0000076334-25-000021.md) | [210 d](/filings/0000076334-26-000105.md) | [210](/filings/0000076334-25-000071.md) | [210 d](/filings/0000076334-26-000008.md) | [210 d](/filings/0000076334-26-000073.md) | [231 d](/filings/0000076334-26-000105.md) | [228](/filings/0000076334-25-000071.md) | [228 d](/filings/0000076334-26-000008.md) | [227 d](/filings/0000076334-26-000073.md) | [253 d](/filings/0000076334-26-000105.md) |
| Share repurchases | $m | [79.3](/filings/0000076334-24-000067.md) | [59.0 d](/filings/0000076334-25-000011.md) | [103 d](/filings/0000076334-25-000021.md) | [91.1 d](/filings/0000076334-26-000105.md) | [94.0](/filings/0000076334-25-000071.md) | [98.0 d](/filings/0000076334-26-000008.md) | [668 d](/filings/0000076334-26-000073.md) | [906 d](/filings/0000076334-26-000105.md) | [522](/filings/0000076334-25-000071.md) | [145 d](/filings/0000076334-26-000008.md) | [340 d](/filings/0000076334-26-000073.md) | [255 d](/filings/0000076334-26-000105.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2022-09-30) | Q2 FY2023 (2022-12-31) | Q3 FY2023 (2023-03-31) | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [130](/filings/0000076334-23-000064.md) | [130](/filings/0000076334-24-000008.md) | [130](/filings/0000076334-24-000020.md) | [130](/filings/0000076334-24-000067.md) | [130](/filings/0000076334-25-000011.md) | [131](/filings/0000076334-25-000021.md) | [131](/filings/0000076334-25-000071.md) | [131](/filings/0000076334-26-000008.md) | [130](/filings/0000076334-26-000073.md) | [128](/filings/0000076334-25-000071.md) | [128](/filings/0000076334-26-000008.md) | [128](/filings/0000076334-26-000073.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 126,047,469 at 2026-07-31, from the cover of the [10-K filed 2026-08-21](/filings/0000076334-26-000105.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:20 ET. No prices; not investment advice.